20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2019

Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient: Hematological Oncology

Caccuri, F., Muraro, E., Gloghini, A., Turriziani, O., Riminucci, M., Giagulli, C., Mastorci, K., Fae', D. A., Fiorentini, S., Caruso, A., Carbone, A. & Dolcetti, R., 2019, In : Hematological Oncology. 37, 2, p. 176-184 9 p.

Research output: Contribution to journalArticle

2017

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy

Montico, B., Lapenta, C., Ravo, M., Martorelli, D., Muraro, E., Zeng, B., Comaro, E., Spada, M., Donati, S., Santini, S. M., Tarallo, R., Giurato, G., Rizzo, F., Weisz, A., Belardelli, F., Dolcetti, R. & Dal Col, J., Nov 2 2017, In : OncoImmunology. 6, 11, e1356964.

Research output: Contribution to journalArticle

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy

Montico, B., Lapenta, C., Ravo, M., Martorelli, D., Muraro, E., Zeng, B., Comaro, E., Spada, M., Donati, S., Santini, S. M., Tarallo, R., Giurato, G., Rizzo, F., Weisz, A., Belardelli, F., Dolcetti, R. & Dal Col, J., Nov 2 2017, In : OncoImmunology. 6, 11, e1356964.

Research output: Contribution to journalArticle

Fighting viral infections and virus-driven tumors with cytotoxic CD4+ T cells

Muraro, E., Merlo, A., Martorelli, D., Cangemi, M., Santa, S. D., Dolcetti, R. & Rosato, A., Feb 27 2017, In : Frontiers in Immunology. 8, FEB, 197.

Research output: Contribution to journalArticle

Fighting viral infections and virus-driven tumors with cytotoxic CD4+ T cells

Muraro, E., Merlo, A., Martorelli, D., Cangemi, M., Santa, S. D., Dolcetti, R. & Rosato, A., Feb 27 2017, In : Frontiers in Immunology. 8, FEB, 197.

Research output: Contribution to journalReview article

Fighting viral infections and virus-driven tumors with cytotoxic CD4+ T cells

Muraro, E., Merlo, A., Martorelli, D., Cangemi, M., Santa, S. D., Dolcetti, R. & Rosato, A., Feb 27 2017, In : Frontiers in Immunology. 8, FEB, 20 p., 197.

Research output: Contribution to journalReview article

Local high-dose radiotherapy induces systemic immunomodulating effects of potential therapeutic relevance in oligometastatic breast cancer

Muraro, E., Furlan, C., Avanzo, M., Martorelli, D., Comaro, E., Rizzo, A., Fae', D. A., Berretta, M., Militello, L., Del Conte, A., Spazzapan, S., Dolcetti, R. & Trovo', M., Nov 6 2017, In : Frontiers in Immunology. 8, 19 p., 1476.

Research output: Contribution to journalArticle

Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial

Trovo, M., Furlan, C., Polesel, J., Fiorica, F., Arcangeli, S., Giaj-Levra, N., Alongi, F., Del Conte, A., Militello, L., Muraro, E., Martorelli, D., Spazzapan, S. & Berretta, M., Jan 1 2017, (Accepted/In press) In : Radiotherapy and Oncology.

Research output: Contribution to journalArticle

2016

Broadening specificity and enhancing cytotoxicity of adoptive T cells for nasopharyngeal carcinoma immunotherapy

Fae, D. A., Martorelli, D., Mastorci, K., Muraro, E., Col, J. D., Franchin, G., Barzan, L., Comaro, E., Vaccher, E., Rosato, A. & Dolcetti, R., May 1 2016, In : Cancer immunology research. 4, 5, p. 431-440 10 p.

Research output: Contribution to journalArticle

Broadening specificity and enhancing cytotoxicity of adoptive T cells for nasopharyngeal carcinoma immunotherapy

Faè, D. A., Martorelli, D., Mastorci, K., Muraro, E., Dal Col, J., Franchin, G., Barzan, L., Comaro, E., Vaccher, E., Rosato, A. & Dolcetti, R., May 1 2016, In : Cancer immunology research. 4, 5, p. 431-440 10 p.

Research output: Contribution to journalArticle

Broadening specificity and enhancing cytotoxicity of adoptive T cells for nasopharyngeal carcinoma immunotherapy

Faè, D. A., Martorelli, D., Mastorci, K., Muraro, E., Col, J. D., Franchin, G., Barzan, L., Comaro, E., Vaccher, E., Rosato, A. & Dolcetti, R., May 1 2016, In : Cancer immunology research. 4, 5, p. 431-440 10 p.

Research output: Contribution to journalArticle

Phamacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer

Miolo, G., Muraro, E., Caruso, D., Crivellari, D., Ash, A., Scalone, S., Lombardi, D., Rizzolio, F., Giordano, A. & Corona, G., 2016, In : Oncotarget. 7, 26, p. 39809-39822 14 p.

Research output: Contribution to journalArticle

Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma

Mastorci, K., Muraro, E., Pasini, E., Furlan, C., Sigalotti, L., Cinco, M., Dolcetti, R. & Fratta, E., 2016, In : PLoS One. 11, 4, p. e0153823

Research output: Contribution to journalArticle

2015

A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting

Martorelli, D., Muraro, E., Mastorci, K., Dal Col, J., Faè, D. A., Furlan, C., Giagulli, C., Caccuri, F., Rusnati, M., Fiorentini, S., Carbone, A., Caruso, A. & Dolcetti, R., Sep 1 2015, In : International Journal of Cancer. 137, 6, p. 1374-1385 12 p.

Research output: Contribution to journalArticle

Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis

Dolcetti, R., Giagulli, C., He, W., Selleri, M., Caccuri, F., Eyzaguirre, L. M., Mazzuca, P., Corbellini, S., Campilongo, F., Marsico, S., Giombini, E., Muraro, E., Rozera, G., De Paoli, P., Carbone, A., Capobianchi, M. R., Ippolito, G., Fiorentini, S., Blattner, W. A., Lu, W. & 2 others, Gallo, R. C. & Caruso, A., Nov 17 2015, In : Proceedings of the National Academy of Sciences of the United States of America. 112, 46, p. 14331-14336 6 p.

Research output: Contribution to journalArticle

2014

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients

Miolo, G., Muraro, E., Martorelli, D., Lombardi, D., Scalone, S., Spazzapan, S., Massarut, S., Perin, T., Viel, E., Comaro, E., Talamini, R., Bidoli, E., Turchet, E., Crivellari, D. & Dolcetti, R., Dec 15 2014, In : BMC Cancer. 14, 1, 954.

Research output: Contribution to journalArticle

2013

Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas

Muraro, E., Martorelli, D. & Dolcetti, R., May 2013, In : Human Vaccines and Immunotherapeutics. 9, 5, p. 1078-1083 6 p.

Research output: Contribution to journalArticle

2012

Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for epstein-barr-virus-driven disorders

Martorelli, D., Muraro, E., Merlo, A., Turrini, R., Faè, D. A., Rosato, A. & Dolcetti, R., 2012, In : Clinical and Developmental Immunology. 2012, 931952.

Research output: Contribution to journalArticle

IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas

Martorelli, D., Guidoboni, M., De Re, V., Muraro, E., Turrini, R., Merlo, A., Pasini, E., Caggiari, L., Romagnoli, L., Spina, M., Mortarini, R., Gasparotto, D., Mazzucato, M., Carbone, A., Rosato, A., Anichini, A. & Dolcetti, R., Aug 1 2012, In : Clinical Cancer Research. 18, 15, p. 4080-4091 12 p.

Research output: Contribution to journalArticle

Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells

Martorelli, D., Coppotelli, G., Muraro, E., Dolcetti, R. & Masucci, M. G., Jun 2012, In : Cancer Immunology, Immunotherapy. 61, 6, p. 881-892 12 p.

Research output: Contribution to journalArticle

Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets

Col, J. D., Mastorci, K., Fae, D. A., Muraro, E., Martorelli, D., Inghirami, G. & Dolcetti, R., Apr 1 2012, In : Cancer Research. 72, 7, p. 1825-1835 11 p.

Research output: Contribution to journalArticle

2011

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: Implications for immune-based therapies

Muraro, E., Martorelli, D., Turchet, E., Miolo, G., Scalone, S., Comaro, E., Talamini, R., Mastorci, K., Lombardi, D., Perin, T., Carbone, A., Veronesi, A., Crivellari, D. & Dolcetti, R., Nov 23 2011, In : Breast Cancer Research. 13, 6, R117.

Research output: Contribution to journalArticle

Cancer vaccines in phase II/III clinical trials: State of the art and future perspectives

Cecco, S., Muraro, E., Giacomin, E., Martorelli, D., Lazzarini, R., Baldo, P. & Dolcetti, R., 2011, In : Current Cancer Drug Targets. 11, 1, p. 85-102 18 p.

Research output: Contribution to journalArticle

2010

Role of CD4 cytotoxic T lymphocytes in the control of viral diseases and cancer

Martorelli, D., Muraro, E., Merlo, A., Turrini, R., Rosato, A. & Dolcetti, R., Jul 2010, In : International Reviews of Immunology. 29, 4, p. 371-402 32 p.

Research output: Contribution to journalArticle

The interplay between Epstein-Barr virus and the immune system: A rationale for adoptive cell therapy of EBV-related disorders

Merlo, A., Turrini, R., Dolcetti, R., Martorelli, D., Muraro, E., Comoli, P. & Rosato, A., Oct 2010, In : Haematologica. 95, 10, p. 1769-1777 9 p.

Research output: Contribution to journalArticle